U.S. Regulators Restrict Imports From Ranbaxy

U.S. Regulators Restrict Imports From Ranbaxy Play

Sept. 17 (Bloomberg) –- Bloomberg's Angie Lau reports on the restrictions U.S. regulators are putting on imports from Ranbaxy's plant in India and the impact the move has across global markets. She speaks to Mia Saini on Bloomberg Television's "First Up." (Source: Bloomberg)

blog comments powered by Disqus